 EX-10.9 9 nvls-20161231ex10947ec03.htm EX-10.9
Exhibit 10.9

AMENDMENT to the
EMPLOYMENT AGREEMENT
between
Nivalis Therapeutics, Inc.
and
Jon Congleton (“Employee”)
 

WHEREAS, Nivalis Therapeutics, Inc. (the “Company”) and the Employee 
entered into an employment agreement (the “Agreement”) effective as of 
January 1, 2015, as amended;
 
WHEREAS, the Company and the Employee desire to amend the Agreement to 
change the provisions relating to the severance payable to Employee and 
relating to the accelerated vesting of stock options in connection with 
Termination/Severance;
 
NOW, THEREFORE, in consideration of the promises and mutual covenants 
contained herein and for other good and valuable consideration, the parties 
agree as follows:
 

1.

Section 5(e)(i) is amended and restated in its entirety to read as follows:
     
       (i) the Company shall pay to Employee as severance an amount equal
       to eighteen (18) month’s Base Salary, in equal installments, subject
       to all applicable deductions and withholdings;
     

2.

Section 5(e)(iii) is amended and restated in its entirety to read as 
follows:
 
    (iii)  the Company shall cause any issued but unvested options to
    immediately vest in full.
     

3.

Except as amended herein, the provisions of the Agreement shall remain in 
full force and effect.
 
IN WITNESS WHEREOF, the Company has caused this Amendment to be executed 
and Employee has hereunto set his hand as of January 12, 2017.
 
 
 
NIVALIS THERAPEUTICS, INC.
 
 
 
By:
/s/ R. Michael Carruthers
 
Name:
R. Michael Carruthers
 
Title:
Chief Financial Officer
 
Date:
1/12/17
 
 
 
 
 
EMPLOYEE
 
 
 
By:
/s/ Jon Congleton
 
 
Jon Congleton
 

------------------------------------------------------------------------